Printed from BusinessInsurance.com

Tighter opioid guidelines adversely impacting some psychiatric prescriptions

Posted On: Dec. 13, 2022 9:31 AM CST

A crackdown by U.S. drug wholesalers in response to the opioid crisis is preventing some pharmacists from dispensing a combination of stimulants and sedatives routinely prescribed by psychiatrists to help patients manage conditions like anxiety and ADHD, Reuters reports. The three main U.S. pharmaceutical wholesalers – AmerisourceBergen Corp., Cardinal Health Inc. and McKesson Corp.  – tightened monitoring of suspicious orders from pharmacies in July as part of a $21 billion nationwide opioid settlement.